Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 - Area 5)

    Alergologia Polska - Polish Journal of Allergology Date published:

  • CHARACTERISTICS OF PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO RESPOND TO GROUND-BASED WALKING TRAINING

    Date published:

  • THE EFFECT ON HRQoL OF ONGOING FEEDBACK DURING A MAINTENANCE WALKING PROGRAM : AN RCT

    Date published:

  • CHOOSING A FASTER WALKING SPEED FOR THE ENDURANCE SHUTTLE WALK TEST MAY REDUCE THE CEILING EFFECT FOR THIS TEST IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Date published:

  • Azithromycin Reduces Exacerbations In Adults With Persistent Symptomatic Eosinophilic Asthma

    Date published:

  • Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

    International Journal of Chronic Obstructive Pulmonary Disease Date published:

  • Perspectives on advance care planning among patients recently requiring non-invasive ventilation for acute respiratory failure: A qualitative study using thematic analysis

    Palliative Medicine Date published:

  • Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

    Internal Medicine Journal Date published:

  • Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

    Internal Medicine Journal Date published:

  • Experience of acute noninvasive ventilation-insights from ‘Behind the Mask’: a qualitative study

    BMJ Supportive & Palliative Care Date published:

  • Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

    Clinical and Translational Allergy Date published:

  • Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

    Clinical & Experimental Allergy Date published:

  • Successes and challenges of COPD management in Australia: reflections on the past and future

    The Lancet Respiratory Medicine Date published:

  • Periostin levels and eosinophilic inflammation in poorly-controlled asthma

    BMC Pulmonary Medicine Date published:

  • AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

    European Respiratory Journal Date published:

  • Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

    European Respiratory Review Date published: